Date
Transaction Number
20192024
Acquiring Party
Highbridge Multi-Strategy Master Fund, L.P.
Acquired Party
Nalpropion Pharmaceuticals, Inc.
Granting Status
Granted
Acquired Entities
Nalpropion Pharmaceuticals, Inc.